Correlation Between Elevai Labs, and Quest Diagnostics

Can any of the company-specific risk be diversified away by investing in both Elevai Labs, and Quest Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elevai Labs, and Quest Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Elevai Labs, Common and Quest Diagnostics Incorporated, you can compare the effects of market volatilities on Elevai Labs, and Quest Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elevai Labs, with a short position of Quest Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elevai Labs, and Quest Diagnostics.

Diversification Opportunities for Elevai Labs, and Quest Diagnostics

-0.79

Correlation Coefficient

Elevai Labs,  Quest Diagnostics

Pay attention - limited upside

The 3 months correlation between Elevai and Quest is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Elevai Labs, Common and Quest Diagnostics Incorporated in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quest Diagnostics and Elevai Labs, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elevai Labs, Common are associated (or correlated) with Quest Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quest Diagnostics has no effect on the direction of Elevai Labs, i.e., Elevai Labs, and Quest Diagnostics go up and down completely randomly.

Pair Corralation between Elevai Labs, and Quest Diagnostics

Given the investment horizon of 90 days Elevai Labs, Common is expected to under-perform the Quest Diagnostics. In addition to that, Elevai Labs, is 8.51 times more volatile than Quest Diagnostics Incorporated. It trades about -0.1 of its total potential returns per unit of risk. Quest Diagnostics Incorporated is currently generating about 0.12 per unit of volatility. If you would invest  15,023  in Quest Diagnostics Incorporated on December 28, 2024 and sell it today you would earn a total of  1,591  from holding Quest Diagnostics Incorporated or generate 10.59% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	98.36%
Values	Daily Returns

Elevai Labs, Common  vs.  Quest Diagnostics Incorporated

Elevai Labs, Common

Risk-Adjusted Performance

Very Weak

Over the last 90 days Elevai Labs, Common has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Quest Diagnostics

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Quest Diagnostics Incorporated are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak technical and fundamental indicators, Quest Diagnostics may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Elevai Labs, and Quest Diagnostics

The main advantage of trading using opposite Elevai Labs, and Quest Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elevai Labs, position performs unexpectedly, Quest Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quest Diagnostics will offset losses from the drop in Quest Diagnostics' long position.

The idea behind Elevai Labs, Common and Quest Diagnostics Incorporated pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.